Shanghai Kaibao Pharmaceutical Long-term Investment Intensity
Shanghai Kaibao Pharmaceutical long-term investment intensity. Shanghai Kaibao Pharmaceutical (300039) has a Long-term Investment Intensity of 6.7% as of September 2019. Long-term investments of CN¥186.49 Million represent 6.7% of total assets of CN¥2.77 Billion. A higher ratio indicates a company with significant capital committed to long-duration strategic positions. Read Shanghai Kaibao Pharmaceutical (300039) financial obligations for a breakdown of total debt and financial obligations.
LT Investment Intensity
Long-term Investments
Total Assets
Country
Long-term Investment Intensity of Shanghai Kaibao Pharmaceutical (2015–2018)
Long-term investment intensity of Shanghai Kaibao Pharmaceutical from 2015 to 2018. This chart shows how Shanghai Kaibao Pharmaceutical's Long-term Investment Intensity has evolved across 4 annual periods from 2015 to 2018. As of September 2019, the intensity stands at 6.7%, reflecting long-term investments of CN¥186.49 Million against total assets of CN¥2.77 Billion CNY.
Shanghai Kaibao Pharmaceutical Long-term Investment Intensity by Year (2015–2018)
Shanghai Kaibao Pharmaceutical long-term investment intensity by year from 2015 to 2018. The table below presents the year-by-year Long-term Investment Intensity for Shanghai Kaibao Pharmaceutical from 2015 to 2018, covering 4 annual filings. Each row shows total assets, long-term investments, the intensity percentage, and the change in percentage points compared to the prior year. For the complete balance sheet picture, see 300039 current and non-current assets.
| Year | LT Investment Intensity | LT Investments (CNY) | Total Assets | Change (pp) |
|---|---|---|---|---|
| 2018 | 6.6% | CN¥182.44 Million | CN¥2.75 Billion | ▲ +0.9 pp |
| 2017 | 5.8% | CN¥154.34 Million | CN¥2.68 Billion | ▼ -1.4 pp |
| 2016 | 7.2% | CN¥180.82 Million | CN¥2.53 Billion | ▲ +4.9 pp |
| 2015 | 2.3% | CN¥55.80 Million | CN¥2.43 Billion | — |